The sheer energy of China’s biomedical ecosystem is producing something that looks like evolution on fast-forward.
Something remarkable is happening in Chinese biotech, and it’s happening fast. The country’s drug developers are learning to run — really run — through clinical trials and regulatory approvals. In an industry famous for glacial timelines and billion-... [596 chars]

